Druggable	Report_C1	Report_C2	Tumor_VAF	Normal_VAF	DP_T	DP_N	SF_TVAF	SF_TDP	CHROM	Start	End	REF	ALT	FILTER	Gene	Transcript	Exon/Intron_Number	cHGVS	pHGVS	Type_Annotation	CLNSIG	CLNCONF	CLNDN	MPOS	POSD
1	NRAS(0.0%)	exon4,c.436G>T,p.A146S	0.000309	0.001077	6989|4	4013|6	0.00158	29745|47	1	115252204	115252204	C	A	clustered_events,strand_bias,weak_evidence	NRAS	NM_002524.5	4	c.436G>T	p.Ala146Ser	missense_variant				55	0.0
1	NRAS(0.0%)	exon2,c.38G>A,p.G13D	0.0004761	0.001356	9079|4	5557|9	0.00039	41436|16	1	115258744	115258746	C	T	clustered_events,normal_artifact,orientation,weak_evidence	NRAS	NM_002524.5	2	c.38G>A	p.Gly13Asp	missense_variant	Pathogenic/Likely_pathogenic		Acute_myeloid_leukemia|Melanoma|Medulloblastoma|Transitional_cell_carcinoma_of_the_bladder|Multiple_myeloma|Malignant_melanoma_of_skin|Juvenile_myelomonocytic_leukemia|Non-Hodgkin_lymphoma|Adenocarcinoma_of_stomach|Neoplasm_of_the_large_intestine|Noonan_syndrome_6|RAS-associated_autoimmune_leukoproliferative_disorder|Myelodysplastic_syndrome|Acute_megakaryoblastic_leukemia_in_down_syndrome|not_provided	30	0.0
1	NRAS(0.0%)	exon2,c.37G>T,p.G13C	0.0001619	0.0005318	9071|5	5559|4	0.00307	41624|128	1	115258745	115258746	C	A	base_qual,clustered_events,normal_artifact,weak_evidence	NRAS	NM_002524.5	2	c.37G>T	p.Gly13Cys	missense_variant	Pathogenic		Melanoma	31	0.0
1	NRAS(0.0%)	exon2,c.35G>T,p.G12V	0.0002794	0.0002697	9038|4	5541|0	0.00153	41790|64	1	115258747	115258748	C	A	clustered_events,weak_evidence	NRAS	NM_002524.5	2	c.35G>T	p.Gly12Val	missense_variant	Pathogenic/Likely_pathogenic		Acute_myeloid_leukemia|Melanoma|Multiple_myeloma|Malignant_melanoma_of_skin|Adenocarcinoma_of_stomach|Neoplasm_of_the_large_intestine|Noonan_syndrome_6|Myelodysplastic_syndrome|Noonan_syndrome|Rasopathy|Malignant_neoplasm_of_body_of_uterus|not_provided	17	0.0
1	NRAS(0.0%)	exon2,c.34G>T,p.G12C	0.0002207	0.0006104	8976|5	5508|4	0.00136	41948|57	1	115258748	115258748	C	A	clustered_events,strand_bias,weak_evidence	NRAS	NM_002524.5	2	c.34G>T	p.Gly12Cys	missense_variant	Pathogenic		Acute_myeloid_leukemia|Melanoma|Multiple_myeloma|Malignant_melanoma_of_skin|Non-small_cell_lung_carcinoma|Adenocarcinoma_of_stomach|Neoplasm_of_the_large_intestine|Myelodysplastic_syndrome|Malignant_neoplasm_of_body_of_uterus|not_provided	26	0.0
-	MSH2(3.3%)	exon2,c.212-5_212-4del	0.033	0.015	320|24	48|1	0.04068	731|31	2	47635523	47635525	CTT	C	multiallelic,normal_artifact,panel_of_normals	MSH2	NM_000251.3	1	c.212-5_212-4del		splice_region_variant&intron_variant				33	0.0
-	MSH2(19.3%)	exon2,c.212-4del	0.193	0.219	320|112	48|22	0.20284	731|186	2	47635523	47635525	CTT	CT	multiallelic,normal_artifact,panel_of_normals	MSH2	NM_000251.3	1	c.212-4del		splice_region_variant&intron_variant	Benign/Likely_benign		Lynch_syndrome_I|Hereditary_cancer-predisposing_syndrome|not_specified|not_provided	41	0.0
-	MSH2(10.3%)	exon2,c.212-4dup	0.103	0.2	320|65	48|18	0.16362	731|143	2	47635523	47635525	CTT	CTTT	multiallelic,normal_artifact,panel_of_normals,suspected_bg	MSH2	NM_000251.3	1	c.212-4dup		splice_region_variant&intron_variant	Benign		Lynch_syndrome_I|Hereditary_cancer-predisposing_syndrome|not_specified|Breast_and/or_ovarian_cancer	38	0.0
-	MSH6(6.4%)	exon5,c.3261del,p.F1088fs	0.064	0.05	4516|367	1125|67	0.05565	12184|718	2	48030639	48030640	AC	A	normal_artifact,panel_of_normals,slippage	MSH6	NM_000179.3	5	c.3261del	p.Phe1088fs	frameshift_variant	Pathogenic		Lynch-like_syndrome|Endometrial_carcinoma|Carcinoma_of_colon|Lynch_syndrome|Hereditary_nonpolyposis_colorectal_cancer_type_5|Hereditary_cancer-predisposing_syndrome|Mismatch_repair_cancer_syndrome_3|Hereditary_nonpolyposis_colorectal_neoplasms|not_provided	38	0.0
	RANBP2(4.2%)	exon20,c.5175A>G,p.E1725=	0.042	0.143	194|9	8|0	0.03519	329|12	2	109382170	109382170	A	G	orientation,panel_of_normals,background	RANBP2	NM_006267.5	20	c.5175A>G	p.Glu1725=	synonymous_variant	Likely_benign		Encephalopathy,_acute,_infection-induced,_3,_suceptibility_to|not_provided	31	0.0
	BMPR2(0.6%)	exon12,c.1748del,p.N583fs	0.006202	0.004992	5549|56	1396|11	0.00816	16164|133	2	203420129	203420130	GA	G	normal_artifact,panel_of_normals	BMPR2	NM_001204.7	12	c.1748del	p.Asn583fs	frameshift_variant	Pathogenic		Pulmonary_arterial_hypertension|Primary_pulmonary_hypertension|Idiopathic_and/or_familial_pulmonary_arterial_hypertension	37	0.0
1	IDH1(0.0%)	exon4,c.395G>T,p.R132L	0.0004829	0.001441	6041|6	1968|2	0.00333	20036|67	2	209113112	209113112	C	A	base_qual,clustered_events,strand_bias,weak_evidence	IDH1	NM_005896.4	4	c.395G>T	p.Arg132Leu	missense_variant	Pathogenic/Likely_pathogenic		Hepatocellular_carcinoma|Acute_myeloid_leukemia|Medulloblastoma|Transitional_cell_carcinoma_of_the_bladder|Multiple_myeloma|Breast_neoplasm|Brainstem_glioma|Malignant_melanoma_of_skin|Lung_adenocarcinoma|Neoplasm_of_brain|Neoplasm_of_the_large_intestine|Adenoid_cystic_carcinoma|Adenocarcinoma_of_prostate|Glioblastoma|Myelodysplastic_syndrome	43	0.0
1	IDH1(0.0%)	exon4,c.394C>T,p.R132C	0.000419	0.0007214	6022|3	1963|0	0.00161	19217|31	2	209113113	209113113	G	A	clustered_events,orientation,strand_bias,weak_evidence	IDH1	NM_005896.4	4	c.394C>T	p.Arg132Cys	missense_variant	Pathogenic/Likely_pathogenic		Hepatocellular_carcinoma|Acute_myeloid_leukemia|Medulloblastoma|Transitional_cell_carcinoma_of_the_bladder|Multiple_myeloma|Astrocytoma|Breast_neoplasm|Brainstem_glioma|Malignant_melanoma_of_skin|Lung_adenocarcinoma|Neoplasm_of_brain|Neoplasm_of_the_large_intestine|Adenoid_cystic_carcinoma|Adenocarcinoma_of_prostate|Glioblastoma|Myelodysplastic_syndrome|not_provided	41	0.0
1	IDH1(0.0%)	exon4,c.394C>A,p.R132S	0.0002426	0.0007951	6022|3	1963|3	0.00291	19217|56	2	209113113	209113113	G	T	clustered_events,orientation,strand_bias,weak_evidence	IDH1	NM_005896.4	4	c.394C>A	p.Arg132Ser	missense_variant	Pathogenic/Likely_pathogenic		Hepatocellular_carcinoma|Acute_myeloid_leukemia|Medulloblastoma|Transitional_cell_carcinoma_of_the_bladder|Multiple_myeloma|Astrocytoma|Breast_neoplasm|Brainstem_glioma|Malignant_melanoma_of_skin|Lung_adenocarcinoma|Neoplasm_of_brain|Neoplasm_of_the_large_intestine|Adenoid_cystic_carcinoma|Adenocarcinoma_of_prostate|Glioblastoma|Myelodysplastic_syndrome	18	0.0
	UGT1A1(1.3%)	exon,c.-55_-54insAT	0.013	0.014	5887|120	4514|98	0.01622	32875|542	2	234668879	234668883	CATAT	CATATAT	clustered_events,multiallelic,normal_artifact,panel_of_normals,suspected_bg	UGT1A1	NM_000463.3		c.-55_-54insAT		upstream_gene_variant	Conflicting_interpretations_of_pathogenicity,_drug_response,_other	Benign(4),Pathogenic(5)	Gilbert_syndrome|Lucey-Driscoll_syndrome|Crigler-Najjar_syndrome,_type_II|Crigler-Najjar_syndrome_type_1|Bilirubin,_serum_level_of,_quantitative_trait_locus_1|Irinotecan_response|not_specified|not_provided	47	0.0
2	FANCD2(5.9%)	exon6,c.378-5del	0.059	0.097	519|40	110|11	0.07979	888|77	3	10076842	10076843	CT	C	multiallelic,normal_artifact,panel_of_normals,slippage	FANCD2	NM_033084.6	5	c.378-5del		splice_region_variant&intron_variant				49	0.0
2	FANCD2(4.9%)	exon6,c.378-5dup	0.049	0.032	519|36	110|7	0.05632	888|53	3	10076842	10076843	CT	CTT	multiallelic,normal_artifact,panel_of_normals,slippage,background	FANCD2	NM_033084.6	5	c.378-5dup		splice_region_variant&intron_variant				39	0.0
	TGFBR2(10.3%)	exon4,c.458del,p.K153fs	0.103	0.098	545|69	57|6	0.08725	1067|102	3	30691871	30691872	GA	G	multiallelic,normal_artifact,panel_of_normals,slippage	TGFBR2	NM_001024847.2	4	c.458del	p.Lys153fs	frameshift_variant	Conflicting_interpretations_of_pathogenicity	Benign(3),Likely_benign(1),Likely_pathogenic(1)	Loeys-Dietz_syndrome|Familial_thoracic_aortic_aneurysm_and_aortic_dissection|not_specified|Cardiovascular_phenotype|not_provided	39	0.0
	ANO10(4.5%)	exon2,c.132del,p.D45fs	0.045	0.035	2795|174	220|8	0.05331	9039|509	3	43647212	43647213	CT	C	multiallelic,normal_artifact,panel_of_normals,slippage	ANO10	NM_018075.5	2	c.132del	p.Asp45fs	frameshift_variant	Pathogenic		not_provided	49	0.0
	ANO10(2.5%)	exon2,c.132dup,p.D45fs	0.025	0.015	2795|89	220|3	0.03419	9039|320	3	43647212	43647213	CT	CTT	multiallelic,normal_artifact,panel_of_normals,slippage,background	ANO10	NM_018075.5	2	c.132dup	p.Asp45fs	frameshift_variant	Pathogenic/Likely_pathogenic		Abnormal_central_motor_function|Spinocerebellar_ataxia,_autosomal_recessive_10|Autosomal_recessive_cerebellar_ataxia|not_provided	50	0.0
	PIK3CB(3.8%)	exon14,c.1810del,p.R604fs	0.038	0.042	350|13	32|0	0.02887	471|14	3	138413709	138413710	CG	C	panel_of_normals	PIK3CB	NM_006219.3	14	c.1810del	p.Arg604fs	frameshift_variant				42	0.0
	ATR(7.9%)	exon10,c.2320del,p.I774fs	0.079	0.097	4773|510	1152|145	0.06426	15799|1085	3	142274739	142274740	AT	A	multiallelic,normal_artifact,panel_of_normals,slippage	ATR	NM_001184.4	10	c.2320del	p.Ile774fs	frameshift_variant	Pathogenic		Endometrial_neoplasm|not_provided	44	0.0
	ATR(1.9%)	exon10,c.2320dup,p.I774fs	0.019	0.026	4773|155	1152|46	0.04109	15799|677	3	142274739	142274740	AT	ATT	multiallelic,normal_artifact,panel_of_normals,slippage,suspected_bg	ATR	NM_001184.4	10	c.2320dup	p.Ile774fs	frameshift_variant	Pathogenic		not_provided	45	0.0
1	PIK3CA(0.1%)	exon10,c.1633G>A,p.E545K	0.001338	0.006702	4660|5	221|0	0.00090	14437|13	3	178936091	178936092	G	A	clustered_events,orientation,weak_evidence	PIK3CA	NM_006218.4	10	c.1633G>A	p.Glu545Lys	missense_variant	Pathogenic/Likely_pathogenic		Cerebrofacial_Vascular_Metameric_Syndrome_(CVMS)|Segmental_undergrowth_associated_with_lymphatic_malformation|Hepatocellular_carcinoma|Abnormality_of_cardiovascular_system_morphology|Pancreatic_adenocarcinoma|Transitional_cell_carcinoma_of_the_bladder|Neoplasm_of_stomach|Breast_neoplasm|Brainstem_glioma|Carcinoma_of_esophagus|Renal_cell_carcinoma,_papillary,_1|Malignant_melanoma_of_skin|Lung_adenocarcinoma|Small_cell_lung_carcinoma|Non-small_cell_lung_carcinoma|Squamous_cell_lung_carcinoma|Neoplasm_of_brain|Seborrheic_keratosis|Neoplasm_of_uterine_cervix|Adenocarcinoma_of_stomach|Sarcoma|Neoplasm_of_ovary|Nasopharyngeal_Neoplasms|Neoplasm_of_the_large_intestine|Carcinoma_of_colon|Carcinoma_of_gallbladder|Breast_adenocarcinoma|Adenocarcinoma_of_prostate|Gallbladder_cancer|Ovarian_Serous_Cystadenocarcinoma|Uterine_Carcinosarcoma|Squamous_cell_carcinoma_of_the_head_and_neck|Megalencephaly-capillary_malformation-polymicrogyria_syndrome|Congenital_lipomatous_overgrowth,_vascular_malformations,_and_epidermal_nevi|Glioblastoma|Papillary_renal_cell_carcinoma,_sporadic|Malignant_neoplasm_of_body_of_uterus|Eccrine_Angiomatous_Hamartoma|OVARIAN_CANCER,_EPITHELIAL,_SOMATIC|PIK3CA_related_overgrowth_spectrum|not_provided	60	0.0
1	PIK3CA(0.0%)	exon10,c.1633G>C,p.E545Q	0.0003143	0.006702	4660|5	221|0	0.00104	14437|15	3	178936091	178936092	G	C	clustered_events,orientation,weak_evidence	PIK3CA	NM_006218.4	10	c.1633G>C	p.Glu545Gln	missense_variant	Pathogenic/Likely_pathogenic,_drug_response		Histone_Methylation_Therapy_response|Hepatocellular_carcinoma|Pancreatic_adenocarcinoma|Transitional_cell_carcinoma_of_the_bladder|Breast_neoplasm|Brainstem_glioma|Carcinoma_of_esophagus|Renal_cell_carcinoma,_papillary,_1|Malignant_melanoma_of_skin|Lung_adenocarcinoma|Small_cell_lung_carcinoma|Non-small_cell_lung_carcinoma|Squamous_cell_lung_carcinoma|Neoplasm_of_brain|Neoplasm_of_uterine_cervix|Adenocarcinoma_of_stomach|Nasopharyngeal_Neoplasms|Neoplasm_of_the_large_intestine|Carcinoma_of_gallbladder|Adenocarcinoma_of_prostate|Head_and_Neck_Neoplasms|Ovarian_Serous_Cystadenocarcinoma|Uterine_Carcinosarcoma|Squamous_cell_carcinoma_of_the_head_and_neck|Glioblastoma|Papillary_renal_cell_carcinoma,_sporadic|Malignant_neoplasm_of_body_of_uterus	40	0.0
1	PIK3CA(0.1%)	exon10,c.1634A>C,p.E545A	0.0006298	0.033	4658|5	214|5	0.00103	14552|15	3	178936092	178936092	A	C	clustered_events,normal_artifact,orientation,weak_evidence	PIK3CA	NM_006218.4	10	c.1634A>C	p.Glu545Ala	missense_variant	Pathogenic		Hepatocellular_carcinoma|Abnormality_of_cardiovascular_system_morphology|Pancreatic_adenocarcinoma|Transitional_cell_carcinoma_of_the_bladder|Breast_neoplasm|Brainstem_glioma|Carcinoma_of_esophagus|Renal_cell_carcinoma,_papillary,_1|Malignant_melanoma_of_skin|Lung_adenocarcinoma|Small_cell_lung_carcinoma|Squamous_cell_lung_carcinoma|Neoplasm_of_brain|Neoplasm_of_uterine_cervix|Adenocarcinoma_of_stomach|Neoplasm_of_ovary|Nasopharyngeal_Neoplasms|Neoplasm_of_the_large_intestine|Carcinoma_of_gallbladder|Adenocarcinoma_of_prostate|Ovarian_Serous_Cystadenocarcinoma|Uterine_Carcinosarcoma|Squamous_cell_carcinoma_of_the_head_and_neck|Glioblastoma|Papillary_renal_cell_carcinoma,_sporadic|Malignant_neoplasm_of_body_of_uterus	22	0.0
1	PIK3CA(0.1%)	exon21,c.3140A>G,p.H1047R	0.0005967	0.003905	7099|4	351|0	0.00035	30976|11	3	178952085	178952085	A	G	clustered_events,orientation,strand_bias,weak_evidence	PIK3CA	NM_006218.4	21	c.3140A>G	p.His1047Arg	missense_variant	Pathogenic		CEREBRAL_CAVERNOUS_MALFORMATIONS_4,_SOMATIC|Cerebrofacial_Vascular_Metameric_Syndrome_(CVMS)|MACRODACTYLY,_SOMATIC|Segmental_undergrowth_associated_with_lymphatic_malformation|Segmental_undergrowth_associated_with_mainly_venous_malformation_with_capillary_component|Hepatocellular_carcinoma|Abnormality_of_cardiovascular_system_morphology|Neoplasm|Medulloblastoma|Adrenocortical_carcinoma|Congenital_macrodactylia|Pancreatic_adenocarcinoma|Transitional_cell_carcinoma_of_the_bladder|Neoplasm_of_stomach|Breast_neoplasm|Brainstem_glioma|Carcinoma_of_esophagus|Renal_cell_carcinoma,_papillary,_1|Malignant_melanoma_of_skin|Rosette-forming_glioneuronal_tumor|Lung_adenocarcinoma|Non-small_cell_lung_carcinoma|Squamous_cell_lung_carcinoma|Neoplasm_of_brain|Seborrheic_keratosis|Neoplasm_of_uterine_cervix|Adenocarcinoma_of_stomach|Neoplasm_of_ovary|Neoplasm_of_the_large_intestine|Carcinoma_of_colon|Breast_adenocarcinoma|Adenocarcinoma_of_prostate|Ovarian_Serous_Cystadenocarcinoma|Uterine_Carcinosarcoma|Squamous_cell_carcinoma_of_the_head_and_neck|Megalencephaly-capillary_malformation-polymicrogyria_syndrome|Congenital_lipomatous_overgrowth,_vascular_malformations,_and_epidermal_nevi|Capillary_malformation_of_the_lower_lip,_lymphatic_malformation_of_face_and_neck,_asymmetry_of_face_and_limbs,_and_partial/generalized_overgrowth|Brain_malformation|Familial_cancer_of_breast|Glioblastoma|Lip_and_oral_cavity_carcinoma|Malignant_neoplasm_of_body_of_uterus|OVARIAN_CANCER,_EPITHELIAL,_SOMATIC|PIK3CA_related_overgrowth_spectrum|not_provided	20	0.0
1	PIK3CA(0.0%)	exon21,c.3140A>T,p.H1047L	0.0002014	0.003905	7099|3	351|0	0.00319	30976|99	3	178952085	178952085	A	T	clustered_events,orientation,strand_bias,weak_evidence	PIK3CA	NM_006218.4	21	c.3140A>T	p.His1047Leu	missense_variant	Pathogenic		CEREBRAL_CAVERNOUS_MALFORMATIONS_4,_SOMATIC|Stroke|Hepatocellular_carcinoma|Hemihypertrophy|Medulloblastoma|Adrenocortical_carcinoma|Pancreatic_adenocarcinoma|Transitional_cell_carcinoma_of_the_bladder|Breast_neoplasm|Brainstem_glioma|Carcinoma_of_esophagus|Renal_cell_carcinoma,_papillary,_1|Malignant_melanoma_of_skin|Lung_adenocarcinoma|Non-small_cell_lung_carcinoma|Squamous_cell_lung_carcinoma|Neoplasm_of_brain|Neoplasm_of_uterine_cervix|Adenocarcinoma_of_stomach|Neoplasm_of_ovary|Macrodactyly_of_toe|Neoplasm_of_the_large_intestine|Breast_adenocarcinoma|Adenocarcinoma_of_prostate|Malignant_Colorectal_Neoplasm|Ovarian_Serous_Cystadenocarcinoma|Uterine_Carcinosarcoma|Cowden_syndrome_1|Squamous_cell_carcinoma_of_the_head_and_neck|Megalencephaly-capillary_malformation-polymicrogyria_syndrome|Congenital_lipomatous_overgrowth,_vascular_malformations,_and_epidermal_nevi|Capillary_malformation_of_the_lower_lip,_lymphatic_malformation_of_face_and_neck,_asymmetry_of_face_and_limbs,_and_partial/generalized_overgrowth|Glioblastoma|Malignant_neoplasm_of_body_of_uterus|PIK3CA_related_overgrowth_spectrum	19	0.0
	MUC4(6.1%)	exon2,c.11517C>G,p.T3839=	0.061	0.058	93|5	17|0	0.04729	544|27	3	195506934	195506934	G	C	suspected_bg	MUC4	NM_018406.7	2	c.11517C>G	p.Thr3839=	synonymous_variant				12	0.0
	FGFR3(2.2%)	exon15,c.2002G>T,p.D668Y	0.022	0.006478	328|6	189|0	0.02422	564|14	4	1808026	1808026	G	T	clustered_events,panel_of_normals,strand_bias,background	FGFR3	NM_000142.5	15	c.2002G>T	p.Asp668Tyr	missense_variant				20	0.0
	FGFR3(2.3%)	exon15,c.2005_2008delinsGTTT,p.R669_V670>VF	0.023	0.006604	323|6	186|0	0.00000	440|0	4	1808029	1808032	CGAG	GTTT	clustered_events,haplotype,panel_of_normals,strand_bias	FGFR3	NM_000142.5	15	c.2005_2008delinsGTTT	p.Arg669_Val670delinsValPhe	missense_variant				18	0.0
1	PDGFRA(0.0%)	exon18,c.2525A>T,p.D842V	0.0004645	0.001251	6594|7	1225|0	0.00255	20771|53	4	55152093	55152093	A	T	base_qual,orientation,strand_bias,weak_evidence	PDGFRA	NM_006206.6	18	c.2525A>T	p.Asp842Val	missense_variant	Conflicting_interpretations_of_pathogenicity	Pathogenic(2),Uncertain_significance(1)	Gastrointestinal_stroma_tumor|not_provided	50	0.0
1	KIT(0.1%)	exon11,c.1669T>A,p.W557R	0.0007543	0.001196	7387|11	1208|1	0.00414	26715|111	4	55593603	55593607	T	A	base_qual,clustered_events,weak_evidence	KIT	NM_000222.3	11	c.1669T>A	p.Trp557Arg	missense_variant	Pathogenic/Likely_pathogenic		Melanoma|Gastrointestinal_stroma_tumor	26	0.0
	KIT(0.0%)	exon11,c.1669T>G,p.W557G	0.0001951	0.001196	7387|3	1208|1	0.00135	26715|36	4	55593603	55593607	T	G	base_qual,clustered_events,weak_evidence	KIT	NM_000222.3	11	c.1669T>G	p.Trp557Gly	missense_variant	Likely_pathogenic		Gastrointestinal_stroma_tumor	24	0.0
1	KIT(0.0%)	exon11,c.1676T>A,p.V559D	0.000293	0.001227	7306|6	1190|1	0.00322	27531|89	4	55593610	55593610	T	A	base_qual,clustered_events,orientation,strand_bias,weak_evidence	KIT	NM_000222.3	11	c.1676T>A	p.Val559Asp	missense_variant	Pathogenic/Likely_pathogenic		Melanoma|Gastrointestinal_stroma_tumor	43	0.0
1	KIT(0.0%)	exon11,c.1676T>G,p.V559G	0.0003742	0.001235	7306|18	1190|1	0.00642	27531|178	4	55593610	55593610	T	G	base_qual,clustered_events,orientation,strand_bias,weak_evidence	KIT	NM_000222.3	11	c.1676T>G	p.Val559Gly	missense_variant	Pathogenic/Likely_pathogenic		Melanoma|Gastrointestinal_stroma_tumor	17	0.0
1	KIT(0.0%)	exon17,c.2459A>T,p.D820V	0.0003776	0.012	6616|5	117|0	0.00218	27420|60	4	55599333	55599333	A	T	base_qual,orientation,strand_bias,weak_evidence	KIT	NM_000222.3	17	c.2459A>T	p.Asp820Val	missense_variant	Likely_pathogenic		Systemic_mast_cell_disease	16	0.0
1	KIT(0.0%)	exon17,c.2460T>G,p.D820E	0.000277	0.012	6629|3	117|0	0.00098	27402|27	4	55599334	55599334	T	G	base_qual,orientation,strand_bias,weak_evidence	KIT	NM_000222.3	17	c.2460T>G	p.Asp820Glu	missense_variant	Pathogenic		Thymoma	66	0.0
	EPHA5(20.7%)	exon8,c.1771G>A,p.G591S	0.207	0.067	645|160	18|0	0.21023	988|263	4	66270111	66270111	C	T	PASS	EPHA5	NM_004439.8	8	c.1771G>A	p.Gly591Ser	missense_variant				39	0.0
	TET2(0.3%)	exon3,c.1201C>T,p.P401S	0.003116	0.006336	3009|10	251|0	0.00176	5683|10	4	106156300	106156300	C	T	PASS	TET2	NM_001127208.3	3	c.1201C>T	p.Pro401Ser	missense_variant				36	0.0
	MSH3(1.5%)	exon7,c.1148del,p.K383fs	0.015	0.017	4857|102	1241|32	0.01853	14721|278	5	79970914	79970915	CA	C	multiallelic,normal_artifact,panel_of_normals,slippage	MSH3	NM_002439.5	7	c.1148del	p.Lys383fs	frameshift_variant	Pathogenic		Endometrial_carcinoma|Hereditary_cancer-predisposing_syndrome|Familial_adenomatous_polyposis_4|not_provided	43	0.0
	MSH3(1.7%)	exon7,c.1148dup,p.N385fs	0.017	0.017	4857|130	1241|30	0.02134	14721|321	5	79970914	79970915	CA	CAA	multiallelic,normal_artifact,panel_of_normals,slippage	MSH3	NM_002439.5	7	c.1148dup	p.Asn385fs	frameshift_variant	Pathogenic		not_provided	44	0.0
-	APC(4.3%)	exon5,c.423-5_423-4del	0.043	0.095	233|17	6|0	0.04453	472|22	5	112111309	112111311	TAA	T	multiallelic,normal_artifact,panel_of_normals	APC	NM_000038.6	4	c.423-5_423-4del		splice_region_variant&intron_variant				44	0.0
-	APC(13.7%)	exon5,c.423-4del	0.137	0.231	233|49	6|3	0.15564	472|87	5	112111309	112111311	TAA	TA	multiallelic,normal_artifact,panel_of_normals	APC	NM_000038.6	4	c.423-4del		splice_region_variant&intron_variant	Benign/Likely_benign		Malignant_Colorectal_Neoplasm|Hereditary_cancer-predisposing_syndrome|Familial_adenomatous_polyposis_1|not_specified|not_provided	37	0.0
-	APC(7.5%)	exon5,c.423-4dup	0.075	0.257	233|31	6|4	0.12104	472|65	5	112111309	112111311	TAA	TAAA	multiallelic,normal_artifact,panel_of_normals,suspected_bg	APC	NM_000038.6	4	c.423-4dup		splice_region_variant&intron_variant	Benign		Familial_adenomatous_polyposis_1|not_specified	45	0.0
	RAD50(5.7%)	exon13,c.2165del,p.K722fs	0.057	0.056	5144|374	905|60	0.05744	18511|1128	5	131931451	131931452	TA	T	multiallelic,normal_artifact,panel_of_normals,slippage	RAD50	NM_005732.4	13	c.2165del	p.Lys722fs	frameshift_variant	Pathogenic		Nijmegen_breakage_syndrome-like_disorder|Hereditary_cancer-predisposing_syndrome	44	0.0
	RAD50(1.6%)	exon13,c.2165dup,p.E723fs	0.016	0.024	5144|128	905|32	0.02773	18511|528	5	131931451	131931452	TA	TAA	multiallelic,normal_artifact,panel_of_normals,slippage,suspected_bg	RAD50	NM_005732.4	13	c.2165dup	p.Glu723fs	frameshift_variant	Pathogenic		Nijmegen_breakage_syndrome-like_disorder|Hereditary_cancer-predisposing_syndrome|Breast_and/or_ovarian_cancer|not_provided	46	0.0
1	EGFR(0.1%)	exon18,c.2125G>A,p.E709K	0.00116	0.0009056	4728|6	2666|2	0.00092	13003|12	7	55241677	55241677	G	A	clustered_events,orientation,strand_bias,weak_evidence	EGFR	NM_005228.5	18	c.2125G>A	p.Glu709Lys	missense_variant	drug_response		Tyrosine_kinase_inhibitor_response	28	0.0
1	EGFR(0.0%)	exon18,c.2126A>T,p.E709V	0.0003358	0.0005631	4674|5	2611|4	0.00249	12829|32	7	55241678	55241678	A	T	base_qual,clustered_events,orientation,weak_evidence	EGFR	NM_005228.5	18	c.2126A>T	p.Glu709Val	missense_variant	Uncertain_significance		not_specified	17	0.0
1	EGFR(0.0%)	exon19,c.2240_2257del,p.L747_P753>S	0.0001561	0.0003578	9334|1	4153|0	0.00000	25797|0	7	55242469	55242487	TTAAGAGAAGCAACATCTC	T	clustered_events,weak_evidence	EGFR	NM_005228.5	19	c.2240_2257del	p.Leu747_Pro753delinsSer	disruptive_inframe_deletion	drug_response		Nonsmall_cell_lung_cancer,_response_to_tyrosine_kinase_inhibitor_in,_somatic|Tyrosine_kinase_inhibitor_response	0	0.0
1	EGFR(0.1%)	exon20,c.2369C>T,p.T790M	0.001218	0.001888	4494|5	2399|4	0.00126	10268|13	7	55249071	55249071	C	T	clustered_events,normal_artifact,orientation,strand_bias,weak_evidence	EGFR	NM_005228.5	20	c.2369C>T	p.Thr790Met	missense_variant	drug_response		Non-small_cell_lung_carcinoma|Lung_carcinoma|Lung_cancer|Hereditary_cancer-predisposing_syndrome|Nonsmall_cell_lung_cancer,_resistance_to_tyrosine_kinase_inhibitor_in|EGFR-related_lung_cancer|Tyrosine_kinase_inhibitor_response|erlotinib_response_-_Efficacy|gefitinib_response_-_Efficacy|not_provided	63	0.0
1	EGFR(0.0%)	exon20,c.2375T>A,p.L792H	0.0003557	0.0006542	4403|4	2366|2	0.00247	10494|26	7	55249077	55249077	T	A	base_qual,clustered_events,orientation,strand_bias,weak_evidence	EGFR	NM_005228.5	20	c.2375T>A	p.Leu792His	missense_variant				37	0.0
1	EGFR(0.1%)	exon20,c.2386G>A,p.G796S	0.001029	0.001142	4346|4	2277|2	0.00153	9759|15	7	55249088	55249088	G	A	clustered_events,orientation,strand_bias,weak_evidence	EGFR	NM_005228.5	20	c.2386G>A	p.Gly796Ser	missense_variant	Conflicting_interpretations_of_pathogenicity	Likely_pathogenic(1),Uncertain_significance(1)	EGFR-related_lung_cancer|not_provided	36	0.0
1	EGFR(0.1%)	exon20,c.2387G>A,p.G796D	0.00129	0.002512	4338|5	2267|5	0.00147	10170|15	7	55249089	55249089	G	A	clustered_events,normal_artifact,orientation,strand_bias,weak_evidence	EGFR	NM_005228.5	20	c.2387G>A	p.Gly796Asp	missense_variant				43	0.0
1	EGFR(0.0%)	exon20,c.2389T>A,p.C797S	0.0003722	0.0006669	4261|5	2220|5	0.00311	9939|31	7	55249091	55249091	T	A	base_qual,clustered_events,orientation,strand_bias,weak_evidence	EGFR	NM_005228.5	20	c.2389T>A	p.Cys797Ser	missense_variant	not_provided		Non-small_cell_lung_carcinoma	29	0.0
1	EGFR(0.0%)	exon20,c.2389T>G,p.C797G	0.0003491	0.0006701	4261|4	2220|4	0.00231	9939|23	7	55249091	55249091	T	G	base_qual,clustered_events,orientation,strand_bias,weak_evidence	EGFR	NM_005228.5	20	c.2389T>G	p.Cys797Gly	missense_variant				40	0.0
1	EGFR(0.1%)	exon21,c.2572C>A,p.L858M	0.00142	0.002122	4144|6	1448|2	0.00262	9152|24	7	55259514	55259514	C	A	clustered_events,normal_artifact,orientation,strand_bias,weak_evidence	EGFR	NM_005228.5	21	c.2572C>A	p.Leu858Met	missense_variant	Uncertain_significance		Non-small_cell_lung_carcinoma|not_specified	56	0.0
1	EGFR(0.0%)	exon21,c.2573T>G,p.L858R	0.0003778	0.001082	4092|4	1434|4	0.00277	9006|25	7	55259515	55259515	T	G	base_qual,clustered_events,orientation,strand_bias,weak_evidence	EGFR	NM_005228.5	21	c.2573T>G	p.Leu858Arg	missense_variant	drug_response		Lung_adenocarcinoma|Non-small_cell_lung_carcinoma|Lung_carcinoma|Adenocarcinoma_of_lung,_response_to_tyrosine_kinase_inhibitor_in,_somatic|Nonsmall_cell_lung_cancer,_response_to_tyrosine_kinase_inhibitor_in,_somatic|Erlotinib_response|Gefitinib_response|Tyrosine_kinase_inhibitor_response|gefitinib_response_-_Efficacy	40	0.0
1	EGFR(0.2%)	exon21,c.2582T>A,p.L861Q	0.001593	0.001102	3901|12	1383|0	0.00421	8518|36	7	55259524	55259524	T	A	base_qual,clustered_events,orientation,weak_evidence	EGFR	NM_005228.5	21	c.2582T>A	p.Leu861Gln	missense_variant	Pathogenic/Likely_pathogenic,_drug_response		Lung_adenocarcinoma|Non-small_cell_lung_carcinoma|Squamous_cell_lung_carcinoma|Tyrosine_kinase_inhibitor_response	27	0.0
1	MET(0.0%)	exon14,c.2888-1G>A	0.0003252	0.003383	10789|3	412|0	0.00043	51230|22	7	116411902	116411902	G	A	orientation,strand_bias,weak_evidence	MET	NM_000245.4	13	c.2888-1G>A		splice_acceptor_variant&intron_variant				15	0.0
1	MET(0.0%)	exon14,c.3007T>A,p.Y1003N	0.0002294	0.00279	10953|4	519|0	0.00262	64299|169	7	116412022	116412022	T	A	base_qual,clustered_events,orientation,strand_bias,weak_evidence	MET	NM_000245.4	14	c.3007T>A	p.Tyr1003Asn	missense_variant				31	0.0
1	MET(0.0%)	exon14,c.3008A>G,p.Y1003C	0.0003249	0.002784	11054|3	524|0	0.00037	65274|24	7	116412023	116412023	A	G	clustered_events,strand_bias,weak_evidence	MET	NM_000245.4	14	c.3008A>G	p.Tyr1003Cys	missense_variant				14	0.0
1	MET(0.0%)	exon14,c.3008A>T,p.Y1003F	0.000449	0.002784	11054|10	524|0	0.00324	65274|212	7	116412023	116412023	A	T	clustered_events,strand_bias,weak_evidence	MET	NM_000245.4	14	c.3008A>T	p.Tyr1003Phe	missense_variant				47	0.0
1	MET(0.1%)	exon14,c.3028G>A,p.D1010N	0.000732	0.002675	11091|8	554|0	0.00056	65938|37	7	116412043	116412043	G	A	clustered_events,strand_bias,weak_evidence	MET	NM_000245.4	14	c.3028G>A	p.Asp1010Asn	missense_variant&splice_region_variant	Pathogenic		Lung_carcinoma	34	0.0
1	MET(0.0%)	exon14,c.3028G>C,p.D1010H	0.0002626	0.002708	11091|5	554|1	0.00112	65938|74	7	116412043	116412043	G	C	clustered_events,strand_bias,weak_evidence	MET	NM_000245.4	14	c.3028G>C	p.Asp1010His	missense_variant&splice_region_variant				23	0.0
1	MET(0.0%)	exon14,c.3028G>T,p.D1010Y	0.000137	0.002708	11091|15	554|1	0.00603	65938|400	7	116412043	116412043	G	T	clustered_events,strand_bias,weak_evidence	MET	NM_000245.4	14	c.3028G>T	p.Asp1010Tyr	missense_variant&splice_region_variant				33	0.0
1	MET(0.1%)	exon14,c.3028+1G>A	0.001015	0.002676	11074|13	553|0	0.00180	66116|119	7	116412044	116412044	G	A	clustered_events,orientation,strand_bias,weak_evidence	MET	NM_000245.4	14	c.3028+1G>A		splice_donor_variant&intron_variant	not_provided		not_provided	44	0.0
1	MET(0.0%)	exon14,c.3028+1G>C	0.0001322	0.005211	11074|3	553|1	0.00106	66116|70	7	116412044	116412044	G	C	clustered_events,orientation,strand_bias,weak_evidence	MET	NM_000245.4	14	c.3028+1G>C		splice_donor_variant&intron_variant	not_provided		not_provided	34	0.0
1	MET(0.0%)	exon14,c.3028+1G>T	0.0001571	0.002676	11074|3	553|0	0.00150	66116|99	7	116412044	116412044	G	T	clustered_events,orientation,strand_bias,weak_evidence	MET	NM_000245.4	14	c.3028+1G>T		splice_donor_variant&intron_variant	risk_factor		Osteofibrous_dysplasia|not_provided	8	0.0
1	MET(0.0%)	exon14,c.3028+2T>A	0.0003468	0.002691	10982|12	549|1	0.00277	65551|182	7	116412045	116412045	T	A	clustered_events,orientation,strand_bias,weak_evidence	MET	NM_000245.4	14	c.3028+2T>A		splice_donor_variant&intron_variant				37	0.0
1	MET(0.0%)	exon14,c.3028+2T>C	0.0004927	0.002687	10982|5	549|0	0.00073	65551|48	7	116412045	116412045	T	C	clustered_events,orientation,strand_bias,weak_evidence	MET	NM_000245.4	14	c.3028+2T>C		splice_donor_variant&intron_variant	not_provided		not_provided	50	0.0
1	MET(0.0%)	exon14,c.3028+3A>G	0.0004548	0.002695	10906|5	544|0	0.00026	65181|17	7	116412046	116412046	A	G	clustered_events,orientation,strand_bias,weak_evidence	MET	NM_000245.4	14	c.3028+3A>G		splice_region_variant&intron_variant				50	0.0
0	BRAF(0.0%)	exon15,c.1803A>C,p.K601N	0.0001874	0.005589	8172|4	269|0	0.00101	32557|33	7	140453132	140453132	T	G	base_qual,clustered_events,strand_bias,weak_evidence	BRAF	NM_004333.6	15	c.1803A>C	p.Lys601Asn	missense_variant	Uncertain_significance		Melanoma|B-cell_chronic_lymphocytic_leukemia|Malignant_melanoma_of_skin|Lung_adenocarcinoma|Adenocarcinoma_of_stomach|Neoplasm_of_the_thyroid_gland|Adenocarcinoma_of_prostate|Rasopathy|Malignant_neoplasm_of_body_of_uterus	18	0.0
	BRAF(0.0%)	exon15,c.1802A>T,p.K601I	0.0001831	0.005546	8186|9	267|0	0.00347	31054|108	7	140453133	140453138	T	A	base_qual,clustered_events,orientation,weak_evidence	BRAF	NM_004333.6	15	c.1802A>T	p.Lys601Ile	missense_variant	Likely_pathogenic		Cardio-facio-cutaneous_syndrome|Rasopathy|not_provided	26	0.0
1	BRAF(0.1%)	exon15,c.1801A>G,p.K601E	0.0007258	0.005753	8190|6	266|1	0.00043	32740|14	7	140453134	140453134	T	C	clustered_events,orientation,strand_bias,weak_evidence	BRAF	NM_004333.6	15	c.1801A>G	p.Lys601Glu	missense_variant	Pathogenic		Neoplasm|Melanoma|B-cell_chronic_lymphocytic_leukemia|Thyroid_cancer,_nonmedullary,_2|Malignant_melanoma_of_skin|Lung_adenocarcinoma|Non-small_cell_lung_carcinoma|Adenocarcinoma_of_stomach|Neoplasm_of_the_thyroid_gland|Carcinoma_of_colon|Adenocarcinoma_of_prostate|Malignant_neoplasm_of_body_of_uterus	53	0.0
	BRAF(0.1%)	exon15,c.1799T>C,p.V600A	0.0005817	0.00553	8125|5	263|0	0.00050	31815|16	7	140453136	140453138	A	G	clustered_events,weak_evidence	BRAF	NM_004333.6	15	c.1799T>C	p.Val600Ala	missense_variant	Likely_pathogenic		Melanoma	35	0.0
1	BRAF(0.0%)	exon15,c.1799T>A,p.V600E	0.0002525	0.00553	8125|8	263|0	0.00426	31815|136	7	140453136	140453138	A	T	clustered_events,weak_evidence	BRAF	NM_004333.6	15	c.1799T>A	p.Val600Glu	missense_variant	Pathogenic,_drug_response,_other		Cystic_epithelial_invagination_containing_papillae_lined_by_columnar_epithelium|Trametinib-Dabrafenib_Response|Vemurafenib-Cobimetinib_Response|Nephroblastoma|Cerebral_arteriovenous_malformation|Neoplasm|Melanoma|Papillary_thyroid_carcinoma|Multiple_myeloma|Brainstem_glioma|Malignant_melanoma_of_skin|Lung_adenocarcinoma|Non-small_cell_lung_carcinoma|Neoplasm_of_brain|Colonic_neoplasm|Neoplasm_of_ovary|Gastrointestinal_stroma_tumor|Neoplasm_of_the_large_intestine|Carcinoma_of_colon|Malignant_neoplastic_disease|Lung_carcinoma|Malignant_Colorectal_Neoplasm|Squamous_cell_carcinoma_of_the_head_and_neck|Cardio-facio-cutaneous_syndrome|Glioblastoma|Germ_cell_tumor,_nonseminomatous|Papillary_renal_cell_carcinoma,_sporadic|Astrocytoma,_low-grade,_somatic|not_provided	50	0.0
0	BRAF(0.0%)	exon15,c.1799T>G,p.V600G	0.0002833	0.00553	8125|4	263|0	0.00154	31815|49	7	140453136	140453138	A	C	clustered_events,weak_evidence	BRAF	NM_004333.6	15	c.1799T>G	p.Val600Gly	missense_variant	Pathogenic		Melanoma|Cardio-facio-cutaneous_syndrome|Rasopathy|not_provided	32	0.0
1	BRAF(0.1%)	exon15,c.1798G>A,p.V600M	0.0007848	0.005593	8146|5	263|0	0.00059	32057|19	7	140453137	140453138	C	T	clustered_events,orientation,strand_bias,weak_evidence	BRAF	NM_004333.6	15	c.1798G>A	p.Val600Met	missense_variant	Likely_pathogenic		Melanoma|Non-small_cell_lung_carcinoma|not_provided	12	0.0
	BRAF(0.1%)	exon15,c.1796C>T,p.T599I	0.0008462	0.00574	8061|7	259|0	0.00099	32136|32	7	140453139	140453139	G	A	clustered_events,strand_bias,weak_evidence	BRAF	NM_004333.6	15	c.1796C>T	p.Thr599Ile	missense_variant	Pathogenic		Neoplasm|Melanoma|Cardiofaciocutaneous_syndrome_1|Noonan_syndrome|Rasopathy|not_provided	41	0.0
	KMT2C(5.2%)	exon38,c.8848C>G,p.H2950D	0.052	0.002661	2369|134	604|1	0.05023	4198|222	7	151873690	151873690	G	C	PASS	KMT2C	NM_170606.3	38	c.8848C>G	p.His2950Asp	missense_variant				48	0.0
-	KMT2C(2.1%)	exon38,c.8390dup,p.E2798fs	0.021	0.02	9256|294	3001|86	0.03737	38927|1511	7	151874147	151874148	CT	CTT	multiallelic,normal_artifact,panel_of_normals,slippage,suspected_bg	KMT2C	NM_170606.3	38	c.8390dup	p.Glu2798fs	frameshift_variant	Pathogenic		not_provided	37	0.0
	RP1L1(4.9%)	exon4,c.3971_4020delinsGG,p.E1324_E1340>G	0.049	0.066	3998|112	1968|77	0.00000	7323|0	8	10467588	10467637	TTCCTCTAACTGCACCCCCTCTTCTTGCAGCCCTTCTTCTGTTTTAGTTT	CC	clustered_events,haplotype,normal_artifact,panel_of_normals	RP1L1	NM_178857.6	4	c.3971_4020delinsGG	p.Glu1324_Glu1340delinsGly	missense_variant&conservative_inframe_deletion	Pathogenic		Retinitis_pigmentosa_88	14	0.0
	NOTCH1(3.6%)	exon34,c.7244_7246del,p.P2415del	0.036	0.014	230|9	87|0	0.02579	340|9	9	139390944	139390947	TGTG	T	panel_of_normals,slippage	NOTCH1	NM_017617.5	34	c.7244_7246del	p.Pro2415del	disruptive_inframe_deletion	Likely_benign		Connective_tissue_disease	49	0.0
	SKIDA1(1.4%)	exon4,c.1253_1270del,p.G418_E423del	0.014	0.00804	356|5	145|0	0.00472	422|2	10	21805481	21805499	TCCTCCTCCTCCTCCTCTC	T	PASS	SKIDA1	NM_207371.4	4	c.1253_1270del	p.Gly418_Glu423del	disruptive_inframe_deletion				32	0.0
1	RET(0.1%)	exon11,c.1900T>C,p.C634R	0.0005991	0.0008308	5241|3	3735|3	0.00039	23340|9	10	43609948	43609948	T	C	strand_bias,weak_evidence	RET	NM_020975.6	11	c.1900T>C	p.Cys634Arg	missense_variant	Pathogenic		Pheochromocytoma|Medullary_thyroid_carcinoma|Thyroid_carcinoma|Multiple_endocrine_neoplasia,_type_1|Multiple_endocrine_neoplasia,_type_2b|Multiple_endocrine_neoplasia,_type_2a|Multiple_endocrine_neoplasia,_type_4|Hereditary_cancer-predisposing_syndrome|Multiple_endocrine_neoplasia,_type_2|not_provided	40	0.0
1	RET(0.1%)	exon11,c.1902C>G,p.C634W	0.0005419	0.0003656	5390|3	3856|2	0.00243	24174|59	10	43609950	43609950	C	G	base_qual,orientation,strand_bias,weak_evidence	RET	NM_020975.6	11	c.1902C>G	p.Cys634Trp	missense_variant	Pathogenic		Pheochromocytoma|Medullary_thyroid_carcinoma|Neoplasm_of_the_thyroid_gland|Multiple_endocrine_neoplasia,_type_1|Multiple_endocrine_neoplasia,_type_2b|Multiple_endocrine_neoplasia,_type_2a|Multiple_endocrine_neoplasia,_type_4|Hereditary_cancer-predisposing_syndrome|Multiple_endocrine_neoplasia,_type_2|not_provided	38	0.0
-	PTEN(6.0%)	exon8,c.802-4_802-3del	0.06	0.102	47|10	10|2	0.04075	306|13	10	89720633	89720635	CTT	C	germline,multiallelic,normal_artifact,panel_of_normals	PTEN	NM_000314.8	7	c.802-4_802-3del		splice_region_variant&intron_variant	Likely_benign		Hereditary_cancer-predisposing_syndrome|not_specified|not_provided	21	0.0
-	PTEN(11.5%)	exon8,c.802-3del	0.115	0.235	47|16	10|4	0.16621	306|61	10	89720633	89720635	CTT	CT	germline,multiallelic,normal_artifact,panel_of_normals	PTEN	NM_000314.8	7	c.802-3del		splice_region_variant&intron_variant	Benign/Likely_benign		Hereditary_cancer-predisposing_syndrome|PTEN_hamartoma_tumor_syndrome|not_specified|Breast_and/or_ovarian_cancer|not_provided	23	0.0
-	PTEN(37.1%)	exon8,c.802-3dup	0.371	0.143	47|37	10|3	0.29002	306|125	10	89720633	89720635	CTT	CTTT	germline,multiallelic,normal_artifact,panel_of_normals,distinguished	PTEN	NM_000314.8	7	c.802-3dup		splice_acceptor_variant&intron_variant	Benign		PTEN_hamartoma_tumor_syndrome|not_specified|not_provided	41	0.0
	MUC2(7.2%)	exon31,c.4736_4738delinsGTA,p.T1579_P1580>ST	0.072	0.067	90|4	19|0	0.00125	797|1	11	1092920	1092922	CCC	GTA	haplotype,orientation,panel_of_normals	MUC2	NM_002457.4	31	c.4736_4738delinsGTA	p.Thr1579_Pro1580delinsSerThr	missense_variant				3	0.0
	OR8I2(42.2%)	exon1,c.705G>A,p.K235=	0.422	0.014	994|705	100|0	0.40355	2016|1364	11	55861488	55861488	G	A	PASS	OR8I2	NM_001003750.1	1	c.705G>A	p.Lys235=	synonymous_variant				41	0.0
-	ATM(28.1%)	exon6,c.497-4del	0.281	0.13	105|51	8|0	0.23138	289|87	11	108114661	108114662	AT	A	germline,panel_of_normals	ATM	NM_000051.4	5	c.497-4del		splice_region_variant&intron_variant	Benign/Likely_benign		Hereditary_cancer-predisposing_syndrome|Familial_cancer_of_breast|not_specified|not_provided	32	0.0
-	ATM(19.6%)	exon10,c.1236-3del	0.196	0.315	49|19	9|9	0.11688	204|27	11	108121410	108121411	CT	C	germline,multiallelic,normal_artifact,panel_of_normals,slippage	ATM	NM_000051.4	9	c.1236-3del		splice_region_variant&intron_variant	Benign/Likely_benign		Ataxia-telangiectasia_syndrome|Hereditary_cancer-predisposing_syndrome|not_specified|Breast_and/or_ovarian_cancer|not_provided	47	0.0
-	ATM(18.7%)	exon10,c.1236-3dup	0.187	0.156	49|16	9|3	0.18400	204|46	11	108121410	108121411	CT	CTT	germline,multiallelic,normal_artifact,panel_of_normals,slippage,suspected_bg	ATM	NM_000051.4	9	c.1236-3dup		splice_acceptor_variant&intron_variant	Benign/Likely_benign		Hereditary_cancer-predisposing_syndrome|not_specified|Breast_and/or_ovarian_cancer|not_provided	34	0.0
	CD3G(5.5%)	exon3,c.213del,p.K71fs	0.055	0.038	2467|161	454|24	0.05660	5167|310	11	118220582	118220583	TA	T	multiallelic,normal_artifact,panel_of_normals,slippage	CD3G	NM_000073.3	3	c.213del	p.Lys71fs	frameshift_variant	Conflicting_interpretations_of_pathogenicity	Pathogenic(1),Uncertain_significance(1)	Immunodeficiency_17	40	0.0
	CD3G(1.3%)	exon3,c.213dup,p.W72fs	0.013	0.037	2467|55	454|22	0.02325	5167|123	11	118220582	118220583	TA	TAA	multiallelic,normal_artifact,panel_of_normals,slippage,suspected_bg	CD3G	NM_000073.3	3	c.213dup	p.Trp72fs	frameshift_variant	Pathogenic		Immunodeficiency_17	46	0.0
	KMT2A(44.7%)	exon2,c.449G>C,p.G150A	0.447	0.053	107|86	26|0	0.43478	130|100	11	118339506	118339506	G	C	PASS	KMT2A	NM_001197104.2	2	c.449G>C	p.Gly150Ala	missense_variant				33	0.0
	CBL(3.7%)	exon9,c.1380_1382del,p.D460del	0.037	0.159	187|6	4|0	0.02508	311|8	11	119149355	119149358	TATG	T	panel_of_normals,slippage,suspected_bg	CBL	NM_005188.4	9	c.1380_1382del	p.Asp460del	disruptive_inframe_deletion	Uncertain_significance		Noonan_syndrome-like_disorder_with_or_without_juvenile_myelomonocytic_leukemia|Rasopathy	39	0.0
1	KRAS(0.1%)	exon4,c.437C>T,p.A146V	0.0006126	0.002783	7711|4	541|0	0.00055	39673|22	12	25378561	25378562	G	A	orientation,weak_evidence	KRAS	NM_033360.4	4	c.437C>T	p.Ala146Val	missense_variant	Pathogenic		OCULOECTODERMAL_SYNDROME,_SOMATIC|Non-small_cell_lung_carcinoma|Neoplasm_of_the_thyroid_gland|Neoplasm_of_the_large_intestine	55	0.0
1	KRAS(0.1%)	exon4,c.436G>T,p.A146S	0.001205	0.002764	7758|11	548|0	0.00237	40062|95	12	25378562	25378562	C	A	orientation,strand_bias	KRAS	NM_033360.4	4	c.436G>T	p.Ala146Ser	missense_variant	Conflicting_interpretations_of_pathogenicity	Likely_pathogenic(1),Uncertain_significance(1)	Rasopathy|not_provided	44	0.0
1	KRAS(0.0%)	exon4,c.436G>A,p.A146T	0.0002939	0.002764	7758|3	548|0	0.00065	40062|26	12	25378562	25378562	C	T	orientation,strand_bias	KRAS	NM_033360.4	4	c.436G>A	p.Ala146Thr	missense_variant	Uncertain_significance		OCULOECTODERMAL_SYNDROME,_SOMATIC|Neoplasm_of_the_large_intestine|not_provided	28	0.0
1	KRAS(0.0%)	exon3,c.182A>T,p.Q61L	0.00021	0.001167	8139|7	1579|3	0.00260	40675|106	12	25380276	25380277	T	A	base_qual,clustered_events,orientation,weak_evidence	KRAS	NM_033360.4	3	c.182A>T	p.Gln61Leu	missense_variant	Pathogenic		Medullary_thyroid_carcinoma|Multiple_myeloma|Non-small_cell_lung_carcinoma|Neoplasm_of_the_thyroid_gland|Neoplasm_of_the_large_intestine	30	0.0
1	KRAS(0.0%)	exon3,c.182A>G,p.Q61R	0.0003876	0.001002	8139|4	1579|0	0.00054	40675|22	12	25380276	25380277	T	C	base_qual,clustered_events,orientation,weak_evidence	KRAS	NM_033360.4	3	c.182A>G	p.Gln61Arg	missense_variant	Conflicting_interpretations_of_pathogenicity	Pathogenic(1),Uncertain_significance(2)	Non-small_cell_lung_carcinoma|Neoplasm_of_the_thyroid_gland|Neoplasm_of_the_large_intestine|Noonan_syndrome|Noonan_syndrome_and_Noonan-related_syndrome|Rasopathy	28	0.0
	KRAS(0.0%)	exon3,c.181C>G,p.Q61E	0.0003232	0.001008	8132|4	1579|0	0.00095	40847|39	12	25380277	25380277	G	C	base_qual,clustered_events,weak_evidence	KRAS	NM_033360.4	3	c.181C>G	p.Gln61Glu	missense_variant	Likely_pathogenic		Neoplasm_of_the_large_intestine	26	0.0
1	KRAS(0.1%)	exon3,c.176C>A,p.A59E	0.0005133	0.001027	7833|5	1530|0	0.00164	38889|64	12	25380282	25380282	G	T	clustered_events,strand_bias,weak_evidence	KRAS	NM_033360.4	3	c.176C>A	p.Ala59Glu	missense_variant				72	0.0
1	KRAS(0.0%)	exon3,c.175G>T,p.A59S	0.0002981	0.001038	7806|3	1523|1	0.00142	38798|55	12	25380283	25380283	C	A	clustered_events,strand_bias,weak_evidence	KRAS	NM_033360.4	3	c.175G>T	p.Ala59Ser	missense_variant	Pathogenic/Likely_pathogenic		not_provided	43	0.0
1	KRAS(0.1%)	exon3,c.175G>A,p.A59T	0.0006424	0.001885	7806|3	1523|2	0.00072	38798|28	12	25380283	25380283	C	T	clustered_events,strand_bias,weak_evidence	KRAS	NM_033360.4	3	c.175G>A	p.Ala59Thr	missense_variant	Pathogenic/Likely_pathogenic		Neoplasm_of_the_large_intestine|Bladder_cancer,_transitional_cell,_somatic	36	0.0
1	KRAS(0.0%)	exon2,c.38G>T,p.G13V	0.0002678	0.000502	9168|4	3002|0	0.00173	40444|70	12	25398281	25398282	C	A	clustered_events,orientation	KRAS	NM_033360.4	2	c.38G>T	p.Gly13Val	missense_variant	Pathogenic		Non-small_cell_lung_carcinoma|Neoplasm_of_the_thyroid_gland|Neoplasm_of_the_large_intestine|not_provided	21	0.0
1	KRAS(0.1%)	exon2,c.38G>A,p.G13D	0.001314	0.0008347	9168|14	3002|1	0.00077	40444|31	12	25398281	25398282	C	T	clustered_events,orientation	KRAS	NM_033360.4	2	c.38G>A	p.Gly13Asp	missense_variant	Conflicting_interpretations_of_pathogenicity	Pathogenic(4),Uncertain_significance(1)	OCULOECTODERMAL_SYNDROME,_SOMATIC|Acute_myeloid_leukemia|Nevus_sebaceous|Juvenile_myelomonocytic_leukemia|Non-small_cell_lung_carcinoma|Neoplasm_of_the_thyroid_gland|Neoplasm_of_ovary|Neoplasm_of_the_large_intestine|Breast_adenocarcinoma|RAS-associated_autoimmune_leukoproliferative_disorder|Noonan_syndrome_and_Noonan-related_syndrome|Inborn_genetic_diseases|not_provided	41	0.0
1	KRAS(0.0%)	exon2,c.37G>T,p.G13C	0.0003172	0.0005062	9183|3	3004|1	0.00167	40747|68	12	25398282	25398282	C	A	clustered_events,orientation,strand_bias,weak_evidence	KRAS	NM_033360.4	2	c.37G>T	p.Gly13Cys	missense_variant	Pathogenic		Non-small_cell_lung_carcinoma|Neoplasm_of_the_large_intestine|RAS-associated_autoimmune_leukoproliferative_disorder|not_provided	17	0.0
1	KRAS(0.1%)	exon2,c.35G>A,p.G12D	0.000706	0.0005054	9171|7	3009|0	0.00082	40445|33	12	25398284	25398285	C	T	clustered_events,orientation,weak_evidence	KRAS	NM_033360.4	2	c.35G>A	p.Gly12Asp	missense_variant	Pathogenic		Vascular_Tumors_Including_Pyogenic_Granuloma|Acute_myeloid_leukemia|Cerebral_arteriovenous_malformation|Neoplasm_of_stomach|Nevus_sebaceous|Epidermal_nevus|Linear_sebaceous_nevus_sequence|Juvenile_myelomonocytic_leukemia|Non-small_cell_lung_carcinoma|Neoplasm_of_the_thyroid_gland|Neoplasm_of_ovary|Neoplasm_of_the_large_intestine|Lung_carcinoma|Carcinoma_of_pancreas|RAS-associated_autoimmune_leukoproliferative_disorder|Capillary_malformation-arteriovenous_malformation_1|Rasopathy|Primary_low_grade_serous_adenocarcinoma_of_ovary|not_provided	44	0.0
1	KRAS(0.0%)	exon2,c.34G>T,p.G12C	0.0004963	0.0005332	9158|7	3006|1	0.00191	40662|78	12	25398285	25398285	C	A	clustered_events,normal_artifact,orientation,strand_bias,weak_evidence	KRAS	NM_033360.4	2	c.34G>T	p.Gly12Cys	missense_variant	Conflicting_interpretations_of_pathogenicity	Likely_pathogenic(1),Pathogenic(7),Uncertain_significance(1)	Endometrial_carcinoma|Lung_adenocarcinoma|Non-small_cell_lung_carcinoma|Neoplasm_of_the_thyroid_gland|Neoplasm_of_ovary|Neoplasm_of_the_large_intestine|Lung_carcinoma|Gallbladder_cancer|not_provided	30	0.0
1	KRAS(0.1%)	exon2,c.34G>A,p.G12S	0.0007129	0.001483	9158|7	3006|4	0.00081	40662|33	12	25398285	25398285	C	T	clustered_events,normal_artifact,orientation,strand_bias,weak_evidence	KRAS	NM_033360.4	2	c.34G>A	p.Gly12Ser	missense_variant	Pathogenic		Stomach_cancer|Juvenile_myelomonocytic_leukemia|Non-small_cell_lung_carcinoma|Neoplasm_of_the_thyroid_gland|Neoplasm_of_ovary|Neoplasm_of_the_large_intestine|not_provided	30	0.0
-	KMT2D(4.4%)	exon11,c.1846_1866delinsTGCCCAGTTCCCCGCCACCTGAA,p.P616fs	0.044	0.05	1271|54	436|19	0.06518	3471|242	12	49445600	49445620	CTCAGGTGGTGGGGAAAGGGG	TTCAGGTGGCGGGGAACTGGGCA	clustered_events,haplotype,normal_artifact,panel_of_normals,strand_bias,background	KMT2D	NM_003482.4	11	c.1846_1866delinsTGCCCAGTTCCCCGCCACCTGAA	p.Pro616fs	frameshift_variant&missense_variant	Pathogenic		not_provided	11	0.0
	GLI1(9.6%)	exon12,c.2090C>T,p.A697V	0.096	0.067	35|3	19|0	0.06667	42|3	12	57864613	57864613	C	T	PASS	GLI1	NM_005269.3	12	c.2090C>T	p.Ala697Val	missense_variant				11	0.0
-	HNF1A(4.0%)	exon4,c.872del,p.P291fs	0.04	0.059	197|8	99|6	0.02857	306|9	12	121432117	121432118	GC	G	normal_artifact,panel_of_normals,slippage,weak_evidence	HNF1A	NM_000545.8	4	c.872del	p.Pro291fs	frameshift_variant	Pathogenic		Monogenic_diabetes|not_provided	32	0.0
-	BRCA2(1.6%)	exon23,c.9097dup,p.T3033fs	0.016	0.026	1229|28	276|9	0.02196	2227|50	13	32954022	32954022	C	CA	normal_artifact,panel_of_normals,slippage	BRCA2	NM_000059.4	23	c.9097dup	p.Thr3033fs	frameshift_variant	Pathogenic		Breast_carcinoma|Neoplasm_of_ovary|Hereditary_breast_and_ovarian_cancer_syndrome|Malignant_tumor_of_breast|Breast-ovarian_cancer,_familial_1|Breast-ovarian_cancer,_familial_2|Hereditary_cancer-predisposing_syndrome|Familial_cancer_of_breast|Breast_and/or_ovarian_cancer|not_provided	51	0.0
-	RB1(3.0%)	exon7,c.608-4del	0.03	0.042	4813|197	595|30	0.03232	23087|771	13	48934140	48934141	AT	A	multiallelic,normal_artifact,panel_of_normals,slippage	RB1	NM_000321.3	6	c.608-4del		splice_region_variant&intron_variant	Likely_benign		Retinoblastoma|Hereditary_cancer-predisposing_syndrome|not_provided	40	0.0
-	RB1(2.7%)	exon7,c.608-4dup	0.027	0.022	4813|172	595|22	0.04211	23087|1015	13	48934140	48934141	AT	ATT	multiallelic,normal_artifact,panel_of_normals,slippage	RB1	NM_000321.3	6	c.608-4dup		splice_region_variant&intron_variant				43	0.0
-	RB1(0.3%)	exon7,c.608-3C>T	0.002701	0.005913	5637|14	719|4	0.00348	27479|96	13	48934150	48934150	C	T	normal_artifact,panel_of_normals,weak_evidence	RB1	NM_000321.3	6	c.608-3C>T		splice_region_variant&intron_variant				42	0.0
	BLM(2.5%)	exon7,c.1544del,p.N515fs	0.025	0.031	9608|355	2003|75	0.02754	39581|1121	15	91304138	91304139	GA	G	multiallelic,normal_artifact,panel_of_normals,slippage	BLM	NM_000057.4	7	c.1544del	p.Asn515fs	frameshift_variant	Pathogenic		Bloom_syndrome	40	0.0
	BLM(1.7%)	exon7,c.1544dup,p.N515fs	0.017	0.022	9608|251	2003|71	0.02985	39581|1218	15	91304138	91304139	GA	GAA	multiallelic,normal_artifact,panel_of_normals,slippage,suspected_bg	BLM	NM_000057.4	7	c.1544dup	p.Asn515fs	frameshift_variant	Pathogenic/Likely_pathogenic		Hereditary_breast_and_ovarian_cancer_syndrome|Bloom_syndrome|Hereditary_cancer-predisposing_syndrome	41	0.0
	CHD2(5.7%)	exon29,c.3734del,p.K1245fs	0.057	0.08	972|57	146|14	0.04756	1602|80	15	93540315	93540316	GA	G	multiallelic,normal_artifact,panel_of_normals,slippage	CHD2	NM_001271.4	29	c.3734del	p.Lys1245fs	frameshift_variant&splice_region_variant	Pathogenic/Likely_pathogenic		Developmental_and_epileptic_encephalopathy_94|History_of_neurodevelopmental_disorder|not_provided	43	0.0
	CHD2(4.2%)	exon29,c.3734dup	0.042	0.045	972|48	146|10	0.04982	1602|84	15	93540315	93540316	GA	GAA	multiallelic,normal_artifact,panel_of_normals,slippage,suspected_bg	CHD2	NM_001271.4	29	c.3734dup		splice_donor_variant&intron_variant	Conflicting_interpretations_of_pathogenicity	Likely_benign(1),Pathogenic(1)	Developmental_and_epileptic_encephalopathy_94	47	0.0
	CHD2(5.8%)	exon33,c.4173dup,p.Q1392fs	0.058	0.074	334|24	40|2	0.05477	535|31	15	93545433	93545433	G	GA	normal_artifact,panel_of_normals,slippage,suspected_bg	CHD2	NM_001271.4	33	c.4173dup	p.Gln1392fs	frameshift_variant	Conflicting_interpretations_of_pathogenicity	Pathogenic(4),Uncertain_significance(1)	CHD2-Related_Disorder|Autistic_behavior|Seizures|Developmental_and_epileptic_encephalopathy_94|Complex_neurodevelopmental_disorder|not_provided	30	0.0
	CREBBP(12.0%)	exon31,c.5979C>T,p.S1993=	0.12	0.077	33|4	17|0	0.09524	38|4	16	3779069	3779069	G	A	orientation	CREBBP	NM_004380.3	31	c.5979C>T	p.Ser1993=	synonymous_variant				47	0.0
	TP53(62.3%)	exon6,c.614A>G,p.Y205C	0.623	0.0004683	2169|3541	3132|0	0.61538	7547|12075	17	7578235	7578235	T	C	PASS	TP53	NM_000546.6	6	c.614A>G	p.Tyr205Cys	missense_variant	Likely_pathogenic		Hepatocellular_carcinoma|Pancreatic_adenocarcinoma|Multiple_myeloma|Breast_neoplasm|Carcinoma_of_esophagus|Renal_cell_carcinoma,_papillary,_1|Non-Hodgkin_lymphoma|Lung_adenocarcinoma|Squamous_cell_lung_carcinoma|Neoplasm_of_brain|Neoplasm_of_the_large_intestine|Ovarian_Serous_Cystadenocarcinoma|Uterine_Carcinosarcoma|Squamous_cell_carcinoma_of_the_head_and_neck|Glioblastoma|Li-Fraumeni_syndrome|Malignant_neoplasm_of_body_of_uterus	40	0.0
	TMEM97(0.2%)	exon3,c.470T>C,p.L157P	0.002109	0.0006897	6760|17	2150|0	0.00217	21604|47	17	26653758	26653758	T	C	PASS	TMEM97	NM_014573.3	3	c.470T>C	p.Leu157Pro	missense_variant				31	0.0
-	NF1(4.1%)	exon2,c.61-4del	0.041	0.041	480|28	72|1	0.03491	774|28	17	29482988	29482989	CT	C	normal_artifact,panel_of_normals,slippage	NF1	NM_000267.3	1	c.61-4del		splice_region_variant&intron_variant	Benign/Likely_benign		Neurofibromatosis,_familial_spinal|Caf??-au-lait_macules_with_pulmonary_stenosis|Neurofibromatosis-Noonan_syndrome|Neurofibromatosis,_type_1|not_specified|not_provided	46	0.0
	XYLT2(2.7%)	exon8,c.1584del,p.G529fs	0.027	0.019	2524|85	1281|33	0.02391	5878|144	17	48433966	48433967	AC	A	normal_artifact,panel_of_normals	XYLT2	NM_022167.4	8	c.1584del	p.Gly529fs	frameshift_variant	Likely_pathogenic		Spondyloocular_syndrome	44	0.0
	RNF43(5.1%)	exon3,c.278C>T,p.A93V	0.051	0.035	120|6	38|0	0.04348	154|7	17	56448369	56448369	G	A	PASS	RNF43	NM_017763.6	3	c.278C>T	p.Ala93Val	missense_variant				34	0.0
	ZNF776(2.0%)	exon3,c.1043_1126del,p.Y348_P375del	0.02	0.01	1616|32	130|1	0.00000	278|0	19	58265512	58265596	CCAGCGAGTTCACACTGGAGAAAGACCTTATCAGTGTGGAGAATGTGGGAAATCGTTTAATCACAAGTGCAACCTCATTCAGCAT	C	clustered_events,panel_of_normals	ZNF776	NM_173632.4	3	c.1043_1126del	p.Tyr348_Pro375del	disruptive_inframe_deletion				19	0.0
	RBM10(20.5%)	exon15,c.1693+1G>A	0.205	0.029	147|36	51|0	0.20870	182|48	X	47041266	47041266	G	A	PASS	RBM10	NM_005676.5	15	c.1693+1G>A		splice_donor_variant&intron_variant				30	0.0
	ATRX(2.3%)	exon10,c.3786_3788del,p.D1263del	0.023	0.02	394|8	70|0	0.01898	517|10	X	76931741	76931744	GTCA	G	panel_of_normals,slippage,suspected_bg	ATRX	NM_000489.6	10	c.3786_3788del	p.Asp1263del	disruptive_inframe_deletion				32	0.0
